|
How many volunteers were present at the Congress? : |
I think it was about 500 participants. |
|
Delegates from which countries presented in the congress? : |
Mostly from European Countries; Spain, France, Belgium, Netherlands |
|
Were the delegates of any other organizations present in the congress? : |
Yes |
|
If yes, please write the names of the organizations in the box : |
Spain Child and Adolescent Psychiatrists |
|
What were the responses to your talking points? Were specific questions or concerns raised? : |
First of all, it was very intersting to our peers that Tehran University of Medical Sciences has faculty members with speciality in clinical pharmacy. I clarified that we have this service in most of universities in Iran. Specific questions were mostly raised on clinical pharmacists interventions and activities in psychiatry wards and the extent of team work here. |
|
If you met staff members, please list their full names & positions. : |
I met some staff members from Belgium. from Leuvon University. |
|
Please inform us if there are any follow up actions we need to talk with the members of the congress : |
Not any special talks , but to improve our international communications globally. I noticed that many researchers were not aware of our research and practice. There is a need to implement more international congresses with international participants in Tehran. We have good research here, our practionioers are up to date and most are evidence based. we have good education. But there is no good interaction with other authorities. |
|
Your experiences about the travel processes(Providing ticket, accommodation,...) : |
Trouble in taking visa, and a very difficult process to pay online for the congress. |
|
Please give a briefing of your own observations and outcomes of the congress: : |
Different aspects were discussed with many conferences were held at the same time. During conference attending, I came to some conclusions regarding new research topics that could be performed here. Regarding up to date evidence based pharmacotherapy I learned some new points, not only new topics, but how to interpret and look into other aspects of an issue. This is important, since a faculty member should know how their counterparts all around the world manage each patient, how they look into complicated clinical scenarios, and what are the common problems they are also encountered with, in everyday practice. |